WW International, Inc., known as Weight Watchers and listed on NASDAQ:WW, is a global wellness company that focuses on weight management and healthy living. The company offers a range of products and services, including digital and in-person workshops, to help individuals achieve their wellness goals. WW competes with other health and wellness companies, such as Noom and MyFitnessPal.
On March 16, 2026, WW reported an earnings per share (EPS) of -$0.58, which was better than the estimated EPS of -$0.93. This performance reflects the company's ability to manage its expenses effectively, despite a challenging market environment. The reported revenue of approximately $161.5 million also surpassed the estimated revenue of about $149.8 million, showcasing WW's strong sales performance.
In the fourth quarter of 2025, WW reported revenue of $161.5 million, exceeding analysts' expectations by 8.7%. However, this was an 11.7% decrease from the same period in 2024. Despite the decline, the company's adjusted EBITDA was $18.04 million, surpassing the forecasted $12.11 million. This indicates that WW is effectively managing its operations to maintain profitability.
A key highlight for WW is the growth in its clinical subscription business, which generated $27 million in revenue for the fourth quarter, marking a 32% increase year-over-year. The company had 130,000 clinical subscribers at the end of 2025, a 42% increase from the previous year. This growth is expected to continue into the first quarter of 2026, driven by the industry's transformation with GLP-1 medications.
The enterprise value to operating cash flow ratio is negative at approximately -0.98, suggesting challenges in cash flow generation. Despite this, WW maintains a low debt-to-equity ratio of about 0.01, reflecting minimal reliance on debt financing.
